New VEGFR inhibitor Fruquintinib to treat metastatic colorectal cancer: Global Phase III trials have begun.
The new coronary pneumonia immune response male and female patients have a stronger and more sustained T-cell response.
Pfizer/BioNTech plans to expand key clinical trials of the new crown vaccine.
The new coronavirus is mutated, does the vaccine work?
Regular operation or market over-aggressive? AstraZeneia's New Crown Vaccine Phase III trial suspended full decryption.
National Health Insurance Administration news the national supplies belt procurement began.
Obesity increases risk of new crown deaths by 40%, study finds
New rules! Online price early warning management, high-priced drug procurement will be focused on monitoring.
Genesis Group successfully completed the amplification and clinical GMP production of a new dual
Islet cell offskin transplant breakthrough New technology successfully reverses type 1 diabetes.
Nature sub-issue: New use of CRISPR solves the problem of gene therapy's vulnerability to failure.
In the field of positive day clear endocrinology to add new Ding Shagritin tablets (Bessin) was approved for listing.
Beijing Forestry Fruit Tree Science Research Institute has made new progress in the study of walnut deep processing.
A new round of medical insurance adjustment, domestic innovative drugs mess up, foreign enterprises "dividend" change?
Johnson and Johnson submitted a application for the listing of a new adaptive drug for Thedarzalex under the skin.
Ganley Pharmaceuticals has submitted an application for a U.S. clinical trial of NASH's new drug ASC42 (FXR astride).
The third batch of drugs centralized procurement pharmaceutical enterprises may have new changes.
Attention: 9000 plus new pig farm put into production, 10000 plus scale pig farm re-breeding!
New rules of the Health and Safety Commission: Doctors will be banned from these acts from October 1.
One vaccination achieved almost complete protection effect Johnson and Johnson's new crown vaccine animal experiment results are excellent.